Logo-apb
Adv Pharm Bull. 2020;10(1): 106-113. doi: 10.15171/apb.2020.013
PMID: 32002368        PMCID: PMC6983997

Research Article

Association of Omentin-1 with Oxidative Stress and Clinical Significances in Patients with Breast Cancer

Nahideh Tahmasebpour 1, Mohammad Ali Hosseinpour Feizi 2, Nasrin Ziamajidi 1, Naser Pouladi 3, Vahid Montazeri 4, Maryam Farhadian 5 ORCID, Roghayeh Abbasalipourkabir 1 * ORCID

Cited by CrossRef: 14


1- Stępień S, Olczyk P, Gola J, Komosińska-Vassev K, Mielczarek-Palacz A. The Role of Selected Adipocytokines in Ovarian Cancer and Endometrial Cancer. Cells. 2023;12(8):1118 [Crossref]
2- Kim J, Kim J, Lee Y. The Role of Adipokines in Tumor Progression and Its Association with Obesity. Biomedicines. 2024;12(1):97 [Crossref]
3- Yang H, Song S, Li J, Li Y, Feng J, Sun Q, Qiu X, Chen Z, Bai X, Liu X, Lian H, Liu L, Bai Y, Zhang G, Nie Y. Omentin-1 drives cardiomyocyte cell cycle arrest and metabolic maturation by interacting with BMP7. Cell Mol Life Sci. 2023;80(7) [Crossref]
4- Englisz A, Smycz-Kubańska M, Mielczarek-Palacz A. Evaluation of the Potential Diagnostic Utility of the Determination of Selected Immunological and Molecular Parameters in Patients with Ovarian Cancer. Diagnostics. 2023;13(10):1714 [Crossref]
5- Asal D, Mesbah N, Abo-Elmatty D, Fathy H, Abdel-Hamed A. Association of vaspin rs2236242 and Val109Asp omentin genes polymorphism and their serum levels with increased risk of breast cancer. Meta Gene. 2022;31:101016 [Crossref]
6- Barartabar Z, Moini N, Abbasalipourkabir R, Mesbah-Namin S, Ziamajidi N. Assessment of Tissue Oxidative Stress, Antioxidant Parameters, and Zinc and Copper Levels in Patients with Breast Cancer. Biol Trace Elem Res. 2023;201(7):3233 [Crossref]
7- Abas A, Sherif M, Elmoneam Farag S, Sahgal P. Diagnostic and Prognostic Role of Serum Omentin and NGAL Levels in Egyptian Breast Cancer Patients. International Journal of Breast Cancer. 2022;2022:1 [Crossref]
8- Paval D, Di Virgilio T, Skipworth R, Gallagher I. The Emerging Role of Intelectin-1 in Cancer. Front Oncol. 2022;12 [Crossref]
9- Panagiotou G, Triantafyllidou S, Tarlatzis B, Papakonstantinou E, Barrientos G. Serum Levels of Irisin and Omentin-1 in Breast Neoplasms and Their Association with Tumor Histology. International Journal of Endocrinology. 2021;2021:1 [Crossref]
10- Pishbin F, Ziamajidi N, Abbasalipourkabir R, Najafi R, Farhadian M. Correlation of Wilms’ Tumor 1 (WT1) with Oxidative Stress Markers and Expression of miR-361-5p; New Aspect of WT1 in Breast Cancer. Ind J Clin Biochem. 2023;38(3):338 [Crossref]
11- Christodoulatos G, Antonakos G, Karampela I, Psallida S, Stratigou T, Vallianou N, Lekka A, Marinou I, Vogiatzakis E, Kokoris S, Papavassiliou A, Dalamaga M. Circulating Omentin-1 as a Biomarker at the Intersection of Postmenopausal Breast Cancer Occurrence and Cardiometabolic Risk: An Observational Cross-Sectional Study. Biomolecules. 2021;11(11):1609 [Crossref]
12- Li J, Tao H, Yuan T, Huang Z, Zhang E. Intelectin-1 is a novel prognostic biomarker for hepatocellular carcinoma. 2023;102(48):e36474 [Crossref]
13- Paval D, Di Virgilio T, Skipworth R, Gallagher I. A systematic review and Bayesian meta-analysis assessing intelectin-1 in cancer patients and healthy individuals. Front Oncol. 2024;14 [Crossref]
14- Brzecka A, Martynowicz H, Daroszewski C, Majchrzak M, Ejma M, Misiuk-Hojło M, Somasundaram S, Kirkland C, Kosacka M. The Modulation of Adipokines, Adipomyokines, and Sleep Disorders on Carcinogenesis. JCM. 2023;12(7):2655 [Crossref]
15- Dec P, Poniewierska-Baran A, Modrzejewski A, Pawlik A. The Role of Omentin-1 in Cancers Development and Progression. Cancers. 2023;15(15):3797 [Crossref]